Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: Results of a multicenter retrospective Korean study (KGOG-1005)

International Journal of Gynecological Cancer

Volumn 17, Issue 1, 2007, Pages 132-136

  Ryu, H S ^a,e   Kang, S B ^b,e   Kim, K T ^c,e   Chang, K H ^a   Kim, J W ^b,e   Kim, J H ^d,e  

^a Ajou University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

^d Yonsei University   (South Korea)

^e Clinical Research Center for Solid Tumors   (South Korea)

Author keywords

Concurrent chemoradiotherapy; FIGO stage IB2 cervical cancer; Neoadjuvant chemotherapy; Radical hysterectomy; Treatment modality

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; REGISTER; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

AGE FACTORS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KOREA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33846798417     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00803.x     Document Type: Article

References (21)

1. International Federation of Gynecology and Obstetrics. Staging announcement: GIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 1995;5:319.
2. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
3. Berek J, Hacker N. Practical gynecologic oncology: cervical cancer. Philadelphia, PA: Lippincott Williams & Wilkins, 2004:360-1.
4. Nelson AJ III, Fletcher GH, Wharton JT. Indications for adjunctive conservative extrafascial hysterectomy in selected cases of carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Nucl Med 1975;123:91- 9.
5. Durrance FY, Fletcher GH, Rutledge FN. Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus. Am J Roentgenol Radium Ther Nucl Med 1969;106:831-8.
6. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WE, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial? Int J Radiat Oncol Biol Phys 1991;21:899-904.
7. Keys HM, Bundy BN, Stehman FB et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the gynecologic oncology group. Gynecol Oncol 2003;89:343-53.
8. Eifel PJ. Chemoradiation for carcinoma of the cervix: advances and opportunities. Radiat Res 2000;154:229-36.
9. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
10. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
11. Kuzuya K. Chemoradiotherapy for uterine cancer: current status and perspectives. Int J Clin Oncol 2004;9:458-70.
12. Sardi J, Sananes C, Giaroli A et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993;49:156-65.
13. Sardi JE, Giaroli A, Sananes C et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997;67:61-9.
14. Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002;20:179-88.
15. Benedetti-Panici PL, Zullo MA, Muzii L et al. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer. Eur J Gynaecol Oncol 2003;24:467-70.
16. Duenas-Gonzalez A, Cetina-Perez L, Onate-Ocana LF et al. Multimodal treatment of locally advanced cervical cancer. Arch Med Res 2005;36:129-35.
17. Yessaian A, Magistris A, Burger RA, Monk BJ. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecol Oncol 2004;94:61-6.
18. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol 1999;73:177-83.
19. Peters WA III, Liu PY, Barrett RJ II et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
20. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 2005;96:490-5.
21. Rocconi RP, Estes JM, Leath CA III, Kilgore LC, Huh WK, Straughn JM Jr. Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis. Gynecol Oncol 2005;97:387-94.